SCHEMBL4510786

SCHEMBL4510786

O=c1c2ncsc2nc(Cc2cc(F)cc(F)c2)n1-c1ccc(Cl)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 3/20 0.34
MPI P34949 1/20 0.34
MAT2A P31153 1/20 0.34
ALDH1A2 O94788 1/20 0.34
ALDH1A3 P47895 1/20 0.34
POLB P06746 1/20 0.33
GSR P00390 1/20 0.32
AOC2 O75106 1/20 0.32
ALDH1A1 P00352 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
EP300 Q09472 1/20 0.32
CREBBP Q92793 1/20 0.32
KAT2A Q92830 1/20 0.32
KAT2B Q92831 1/20 0.32
PI4KB Q9UBF8 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
GRM1 Q13255 1/20 0.31
RGS4 P49798 1/20 0.31
RGS8 P57771 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4506370 0.88 MIF (0.34) MIFMPIMAT2APOLBGSR
SCHEMBL4518585 0.84 GSR (0.37) MIFMPIMAT2AALDH1A2ALDH1A3
SCHEMBL4523287 0.80 MIF (0.37) MIFALDH1A2ALDH1A3POLBEP300
SCHEMBL4521209 0.77 ALDH1A3 (0.39) MAT2AALDH1A2ALDH1A3POLBGSR
SCHEMBL4510077 0.76 PDE10A (0.34) MIFMAT2APOLBAOC2EP300
SCHEMBL4520072 0.76 MAT2A (0.38) MAT2AALDH1A2ALDH1A3POLBGSR
SCHEMBL5429559 0.76 ALDH1A3 (0.59) ALDH1A2ALDH1A3POLBALDH1A1
SCHEMBL4520411 0.75 GRM1 (0.35) MAT2APOLBEP300CREBBPKAT2A
SCHEMBL4530016 0.74 CNR1 (0.39) ALDH1A2ALDH1A3ALDH1A1NPC1RAB9A
SCHEMBL4509906 0.74 DRD1 (0.50) POLBPI4KBGRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298856-A1 2,3 Substituted fused bicyclic pyrimidin-4(3H)-ones modulating the function of the vanilliod-1receptor (VR1) BROWN REBECCA ELIZABETH 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298856-A1 2,3 Substituted fused bicyclic pyrimidin-4(3H)-ones modulating the function of the vanilliod-1receptor (VR1) TRPV1, TRPV2, TRPV4 MIF 3011/4885MPI 4373/4885MAT2A 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.